Ferguson Wellman Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$219K Buy
+941
New +$218K ﹤0.01% 408
2022
Q1
– Sell
-1,252
Closed -$217K – 343
2021
Q4
$217K Buy
+1,252
New +$190K 0.01% 322
2019
Q3
– Sell
-4,000
Closed -$407K – 346
2019
Q2
$407K Hold
4,000
– – 0.01% 264
2019
Q1
$360K Hold
4,000
– – 0.01% 272
2018
Q4
$333K Sell
4,000
-300
-7% -$28.1K 0.01% 281
2018
Q3
$464K Hold
4,300
– – 0.02% 246
2018
Q2
$473K Hold
4,300
– – 0.02% 245
2018
Q1
$431K Hold
4,300
– – 0.02% 257
2017
Q4
$424K Hold
4,300
– – 0.01% 263
2017
Q3
$403K Hold
4,300
– – 0.01% 252
2017
Q2
$478K Buy
4,300
+40
+0.9% +$4.23K 0.02% 237
2017
Q1
$418K Buy
4,260
+300
+8% +$28.6K 0.02% 247
2016
Q4
$364K Buy
3,960
+60
+2% +$5.17K 0.01% 260
2016
Q3
$330K Sell
3,900
-3,000
-43% -$252K 0.01% 254
2016
Q2
$562K Buy
6,900
+3,000
+77% +$228K 0.02% 208
2016
Q1
$279K Sell
3,900
-142
-4% -$9.52K 0.01% 269
2015
Q4
$288K Buy
4,042
+142
+4% +$9.55K 0.01% 279
2015
Q3
$240K Hold
3,900
– – 0.01% 286
2015
Q2
$283K Hold
3,900
– – 0.01% 287
2015
Q1
$300K Hold
3,900
– – 0.01% 279
2014
Q4
$262K Hold
3,900
– – 0.01% 297
2014
Q3
$237K Hold
3,900
– – 0.01% 297
2014
Q2
$229K Hold
3,900
– – 0.01% 304
2014
Q1
$226K Hold
3,900
– – 0.01% 295
2013
Q4
$209K Sell
3,900
-400
-9% -$23.7K 0.01% 303
2013
Q3
$266K Hold
4,300
– – 0.01% 261
2013
Q2
$261K Buy
+4,300
New +$256K 0.02% 165

Other funds holding DGX

Ferguson Wellman Capital Management's DGX Position: Q3 2026 in Review

Ferguson Wellman Capital Management opened a new position in Quest Diagnostics (DGX) in Q3 2026: 941 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #408 among its holdings. This is a return to the name: Ferguson Wellman Capital Management previously reported a position in DGX as recently as Q4 2021.

Ferguson Wellman Capital Management first reported a position in DGX in Q2 2013 and has held it in 27 quarters since. The position peaked at $562K in Q2 2016. 15 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Ferguson Wellman Capital Management held 941 shares of Quest Diagnostics worth $219K as of Q3 2026.
  • Quest Diagnostics was a new Ferguson Wellman Capital Management position in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of Ferguson Wellman Capital Management's portfolio in Q3 2026, its #408 holding.
  • Ferguson Wellman Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 27 quarters since.
  • Ferguson Wellman Capital Management's Quest Diagnostics position peaked at $562K in Q2 2016.
  • 15 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.